Top Markets
Coin of the day
Cardax, Inc. Cardax, Inc.

Cardax, Inc.

CDXI
Rankning i aktier #42795
Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and... Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and marketing nutritional supplements for maintaining inflammatory well-being, as well as developing pharmaceutical treatments for chronic ailments rooted in inflammation and oxidative stress. Its product portfolio includes ZanthoSyn, an advanced supplement for inflammation, health, and longevity that delivers astaxanthin with superior absorption and purity. This product is primarily distributed through online sales and wholesale channels. The company is also progressing two pharmaceutical candidates: CDX-101, an astaxanthin-derived drug candidate intended to address cardiovascular inflammation and dyslipidemia, with a primary focus on severe hypertriglyceridemia; and CDX-301, a zeaxanthin-based pharmaceutical currently under development for macular degeneration. Cardax, Inc. maintains its headquarters in Honolulu, Hawaii.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-11
Marknadsvärde
$80.00
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Cardax, Inc. (CDXI)

Kategori

Aktiekurshistorik för Cardax, Inc. (CDXI)
Högsta slutkurs: $0.00 den 2026-08-01

Lägsta slutkurs: $30.00 den 2013-03-01
Aktiekurshistorik för Cardax, Inc. från 2013 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 0.00%
2025 4.48%
2024 -91.30%
2023 196.15%
2022 -99.95%
2021 -55.81%
2020 -84.57%
2019 -71.42%
2018 4.39%
2017 84.68%
2016 -60.73%
2015 -35.26%
2014 157.83%
2013 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR